From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance

From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance

Monoclonal gammopathy and peripheral neuropathy are common diseases of elderly patients, and almost 10% of patients with neuropathy of unknown cause have paraprotein. However, growing evidence suggests that several hematological malignancies synthesize and release monoclonal proteins that damage the...

Full description

Bibliographic Details
Main Authors: Andrea Visentin, Stefano Pravato, Francesca Castellani, Marta Campagnolo, Francesco Angotzi, Chiara Adele Cavarretta, Alessandro Cellini, Valeria Ruocco, Alessandro Salvalaggio, Alessandra Tedeschi, Livio Trentin, Chiara Briani
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Cancers
Subjects:
monoclonal gammopathies of neurological significance (MGNS)
anti-myelin-associated-glycoprotein (MAG) polyneuropathy
POEMS syndrome
Castleman’s disease
ibrutinib
rituximab
Online Access:https://www.mdpi.com/2072-6694/14/6/1562

Internet

https://www.mdpi.com/2072-6694/14/6/1562

Similar Items